Opioids in cancer: The κ‑opioid receptor (Review)
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Effects of Kappa Opioid Agonists on Cocaine- and Food-Maintained Responding by Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
Effects of the kappa opioid receptor agonist nalfurafine on IFN-γ⁺CD4⁺... | Download Scientific Diagram
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
κ-opioid receptor - Wikipedia
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
BRL 52537 hydrochloride, kappa-opioid agonist (CAS 112282-24-3) (ab120669)
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Understanding opioids in veterinary medicine
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Human native kappa opioid receptor functions not predicted by recombinant receptors: Implications for drug design | Scientific Reports
The Kappa Opioid Receptor | SpringerLink
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Κ-opioid receptor - an overview | ScienceDirect Topics
Innovation – Cara Therapeutics
